AvePoint (Nasdaq: AVPT), the global leader in data security, governance, and resilience, has submitted an application to list ...

Firefly Neuroscience (AIFF) highlights two impactful studies that demonstrate the utility of advanced Resting Electroencephalograms and ...

Growing body of clinical evidence supports use of Company’s FDA-Cleared BNA™ platform to provide objective measures of drug efficacy and cognitive change, driving innovation in brain health Company ...

Firefly Neuroscience, Inc. (NASDAQ:AIFF – Get Free Report) traded down 3.9% during mid-day trading on Tuesday . The stock traded as low as $3.43 and last traded at $3.70. 523,068 shares changed hands ...

EconoTimes is a global, independent publication that delivers comprehensive news, analysis, and insights on the economy, finance, and markets. Based in Korea, we offer a unique perspective on global ...

Enhance your stock picks with dividend metrics like per-share dividends, yield, frequency, payout ratios, and more.

Highlights,Firefly’s BNA™ platform successfully estimates biological brain age using cognitive ERP data.,New method could revolutionize early screening for Alzheimer's and dementia risk.,Research ...

The Indian rupee continued its strong downward trend as the rising US dollar and bond yields affected the country’s economy. The USD/INR exchange rate has risen for 11 straight weeks and is trading at ...

On Tuesday, Firefly Neuroscience Inc (AIFF) stock saw a modest uptick, ending the day at $3.15 which represents a slight increase of $1.25 or 65.79% from the prior close of $1.9. The stock opened at ...

KENMORE, N.Y., Jan. 14, 2025 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc. ("Firefly" or the "Company") (NASDAQ: AIFF), an Artificial Intelligence ("AI") company ...

Measuring brain age with EEG and BNA™ could lead to a proactive and scalable approach to early screening for Alzheimer's patients KENMORE, N.Y., Jan. 14, 2025 (GLOBE NEWSWIRE) -- Firefly Neuroscience, ...